Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Balamurugan Tangiisuran, Ph.D.

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists320202601.240 Why?
Malaysia1520221071.110 Why?
Community Pharmacy Services12020520.690 Why?
Health Knowledge, Attitudes, Practice3202040160.680 Why?
Household Products12018270.640 Why?
Nonprescription Drugs120201180.640 Why?
Accidents120181650.590 Why?
Poisoning120182520.570 Why?
Nursing Staff120171130.530 Why?
Medication Therapy Management120171300.520 Why?
Pesticides120182960.520 Why?
Intention120183470.510 Why?
Inappropriate Prescribing220142110.460 Why?
Long-Term Care120176330.420 Why?
Medication Adherence3201921760.410 Why?
Hypoglycemia120198830.390 Why?
Respiratory Tract Infections1202010100.390 Why?
Anti-Bacterial Agents2202074070.380 Why?
Delphi Technique120158460.370 Why?
Hyperglycemia1201913760.360 Why?
Poisons22022380.350 Why?
Nursing Homes2201410820.320 Why?
Attitude of Health Personnel4201738890.300 Why?
Guideline Adherence2201522200.290 Why?
Nigeria220207700.270 Why?
Hypoglycemic Agents1201930850.270 Why?
Hospitalization52016107210.270 Why?
Physicians2202145910.250 Why?
Renal Insufficiency, Chronic1201922430.250 Why?
Caregivers1201722380.240 Why?
Disease Management1201525080.230 Why?
Cross-Sectional Studies92020261270.210 Why?
Models, Theoretical1201435750.210 Why?
Diabetes Mellitus, Type 232020121480.190 Why?
Emergency Service, Hospital2202078790.180 Why?
Drug Prescriptions2201016700.180 Why?
Adverse Drug Reaction Reporting Systems220174940.180 Why?
Nicotinic Agonists120222650.170 Why?
Polypharmacy120213060.160 Why?
Legislation, Drug120202140.150 Why?
Substance Withdrawal Syndrome120226250.140 Why?
Drugs, Chinese Herbal120191440.140 Why?
Algorithms22017140320.120 Why?
Homes for the Aged120172720.120 Why?
Perception2201911970.120 Why?
Antidepressive Agents2201728970.120 Why?
Sex Distribution1201822810.110 Why?
Quality of Life22019133670.110 Why?
Aged1320211693100.110 Why?
Male1820203608420.100 Why?
Needs Assessment1201811390.100 Why?
Databases as Topic120144730.100 Why?
Nutritional Support120141730.100 Why?
Inpatients3201725480.100 Why?
Humans2620227615720.100 Why?
Female1820203926860.100 Why?
Geriatric Assessment2201714100.090 Why?
Prevalence32019157320.090 Why?
General Practitioners120121010.090 Why?
Qualitative Research1202130230.090 Why?
Professional Competence120144310.090 Why?
Heart Failure12015116700.090 Why?
Nutrition Assessment120147280.090 Why?
Medication Reconciliation120121530.090 Why?
Aged, 80 and over72017589860.090 Why?
Patient Education as Topic1201923190.080 Why?
Depressive Disorder, Major2201747610.080 Why?
Hospitals, University120105640.080 Why?
Retrospective Studies82022806460.080 Why?
Antihypertensive Agents2202020240.070 Why?
Europe1201434220.070 Why?
Stroke2202097580.070 Why?
Hospitals, Teaching1201211560.070 Why?
Malnutrition120146450.070 Why?
Prospective Studies52020544260.070 Why?
Brain Ischemia1202030490.070 Why?
Pilot Projects1202086330.070 Why?
Drug Utilization1201211880.070 Why?
Risk Factors82020742130.070 Why?
Middle Aged920202209200.060 Why?
Follow-Up Studies22019391070.060 Why?
Continuity of Patient Care1201210690.060 Why?
Primary Health Care1202146860.060 Why?
Comorbidity22019105080.060 Why?
Incidence22020213550.060 Why?
Patient Discharge2201634430.050 Why?
Recurrence3202084660.050 Why?
Risk Assessment42020239960.050 Why?
Multivariate Analysis12014120590.050 Why?
Pulmonary Disease, Chronic Obstructive1201632040.050 Why?
Anxiety1201645730.050 Why?
Adult720222212030.050 Why?
Neuropsychological Tests1201470540.050 Why?
Child, Preschool22022422300.040 Why?
Bupropion120223040.040 Why?
Quinoxalines120222960.040 Why?
Benzazepines120223100.040 Why?
Reproducibility of Results22017200990.040 Why?
Epirubicin12019810.040 Why?
Prognosis12019296290.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019117420.040 Why?
Obesity12020129470.040 Why?
Hypertension2202085400.040 Why?
Depression1201681240.030 Why?
Complementary Therapies120194860.030 Why?
Practice Guidelines as Topic1201273910.030 Why?
Fluorouracil1201916420.030 Why?
Registries2202082240.030 Why?
Pharmaceutical Preparations1202210890.030 Why?
Cyclophosphamide1201922200.030 Why?
Educational Status1202025220.030 Why?
Personnel, Hospital120142850.020 Why?
Breast Neoplasms12019210170.020 Why?
Child12020801560.020 Why?
Blood Pressure Monitoring, Ambulatory120122440.020 Why?
Aging1200987110.020 Why?
Myocardial Ischemia1202021130.020 Why?
Hospital Administration120123530.020 Why?
Time Factors22020399700.020 Why?
Life Style1201939170.020 Why?
Health Status1201940770.020 Why?
Treatment Outcome32022646840.020 Why?
Sex Factors12019105530.020 Why?
Nutritional Status1201416150.020 Why?
Smoking1202290530.020 Why?
Medication Errors120107830.010 Why?
Neoplasm Staging12019111210.010 Why?
Longitudinal Studies12019146070.010 Why?
Body Mass Index12020129540.010 Why?
Self Report1201437250.010 Why?
Quality Indicators, Health Care1201217920.010 Why?
Infant, Newborn12022261980.010 Why?
Patient Readmission1201632710.010 Why?
Sensitivity and Specificity12017146660.010 Why?
Hospitals1201438820.010 Why?
Infant12022361920.010 Why?
Cohort Studies12022414930.010 Why?
Disease Progression12016135100.010 Why?
Mass Screening1201454280.010 Why?
Adolescent12022883240.010 Why?
Tangiisuran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.